Across TCGA cell cohorts, PRAMEF20 RNA expression is significantly associated with the mutation status of many other genes, with 346 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible PRAMEF20-associated genes across cancer lineages are OGDH, CPD, and CTR9. Each is linked with PRAMEF20 in more than 1 cancer types. Because this analysis shows association rather than direction, both PRAMEF20-to-partner and partner-to-PRAMEF20 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (PRAMEF20→partner) and Y-score (partner→PRAMEF20) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
OESOPHAGUS	OGDH →	+4.906	+0.013	.006	<.001	3	2
OESOPHAGUS	CPD →	+4.906	+0.013	.006	<.001	3	2
LUNG_NSCLC_LUSC	CTR9 →	+4.643	+0.150	.008	.002	3	2
LUNG_SCLC	EIF4G3 →	+3.684	+0.250	.001	<.001	3	2
LARGE_INTESTINE	JPH4 →	+4.022	+0.010	.006	<.001	3	2
LUNG_NSCLC_LUAD	GPR182 →	+5.662	+0.023	.002	<.001	3	2

Each partner links to its Q-omics profile. Showing the 6 strongest of 346 associations by consensus.

Exploration

PRAMEF20 survival (RNA) · tumor vs normal (RNA) · all PRAMEF20 data types